(19)
(11) EP 1 862 158 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
03.04.2013 Bulletin 2013/14

(45) Mention of the grant of the patent:
29.08.2012 Bulletin 2012/35

(21) Application number: 05806436.1

(22) Date of filing: 31.10.2005
(51) International Patent Classification (IPC): 
A61P 25/24(2006.01)
A61K 36/258(2006.01)
 A61K 36/484(2006.01)
A61K 36/725(2006.01)
(86) International application number:
PCT/CN2005/001796
(87) International publication number:
WO 2006/099783 (28.09.2006 Gazette 2006/39)

(54)

A PHARMACEUTICAL COMPOSITION FOR TREATING DEPRESSION AND METHOD FOR PREPARATION THEREOF

PHARMAZEUTISCHE ZUSAMMENSETZUNG ZUR BEHANDLUNG VON DEPRESSION UND HERSTELLUNGSVERFAHREN DAFÜR

PRÉPARATION PHARMACEUTIQUE POUR LE TRAITEMENT DE LA DÉPRESSION ET MÉTHODE D'ÉLABORATION DE LADITE PRÉPARATION

(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

(30) Priority: 25.03.2005 CN 200510058987

(43) Date of publication of application:
05.12.2007 Bulletin 2007/49

(60) Divisional application:
09157704.9 / 2110135

(73) Proprietors:
  • Beijing Wonner Biotech Ltd. Co.
    Chao Yang District, Beijing 100102 (CN)
  • ZHANG, Zuoguang
    100021 (CN)
  • Chi, Yu-Fen
    Taiwan (CN)

(72) Inventor:
  • ZHANG, Zuoguang
    Beijing 100021 (CN)

(74) Representative: Isarpatent 
Patent- und Rechtsanwälte Postfach 44 01 51
80750 München
80750 München (DE)


(56) References cited: : 
CN-A- 1 308 959
CN-A- 1 611 232
 CN-A- 1 312 089
   
  • DATABASE TCM [Online] SIPO; 22 August 2001 (2001-08-22), "A medicine, Energy Pleasing and the depressed vital energy dispersing prescription, for the treatment of psychosis/A pharmaceutical composition for the treatment of psychosis" XP002471316 Database accession no. CN-01100556-A & CN 1 308 959 A (WANG DONGQIAO [CN] INT EPODOC Caesar accession number: CN1308959 WANG) 22 August 2001 (2001-08-22)
  • DATABASE WPI Week 200572 Thomson Scientific, London, GB; AN 2005-695320 XP002487255 & JP 2005 278604 A (DAICHO KIKAKU YG) 13 October 2005 (2005-10-13)
  • NATIONAL PHARMACOPEIA COMMITTEE: 'Pharmacopeia of People's Republic of China', vol. 1ST PART, 31 January 2000 page 559
 
Remarks:
The file contains technical information submitted after the application was filed and not included in this specification
 
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).